Page 9«..891011..»

Category Archives: Cardiovascular Pharmacology

Research Paper Stresses Importance of Repurposing Drugs Against COVID-19 – BioSpace

Posted: Published on May 13th, 2020

The world waits with bated breath for a vaccine for COVID-19, but some researchers believe that drugs to treat the disease will be approved before any vaccine candidate. And one way to get faster treatments for the disease is to repurpose older drugs. That thought has already borne fruit with the recent regulatory approval of Gilead Sciences remdesivir, an experimental drug initially developed to treat Ebola. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Research Paper Stresses Importance of Repurposing Drugs Against COVID-19 – BioSpace

National Nurses Week 2020: What Experiences Have Shaped Your Nursing Career? – HealthLeaders Media

Posted: Published on May 2nd, 2020

2020 is designated as the Year of the Nurse and of the Midwife by the World Health Organization. Unfortunately, it's also been the year of the coronavirus pandemic. And so, as it came time for me to write my annual article to commemorate National Nurses Week, I felt a little strange Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on National Nurses Week 2020: What Experiences Have Shaped Your Nursing Career? – HealthLeaders Media

This Simple Breathing Advice From A Nobel Prize Winner Can Turn The Tables On Stress During The Coronavirus Lockdown – Forbes

Posted: Published on May 2nd, 2020

Getty Just breathe is basic advice thats easy to ignore. But when dealing with increased stressas we are during these strange pandemic weekssimple, controlled breathing is one of the best tools available for getting a grip on our emotions and the effects of stress on our bodies. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on This Simple Breathing Advice From A Nobel Prize Winner Can Turn The Tables On Stress During The Coronavirus Lockdown – Forbes

GLYCOMIMETICS : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) – marketscreener.com

Posted: Published on May 2nd, 2020

Certain statements contained in this Quarterly Report on Form 10-Q mayconstitute forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. The words or phrases "would be," "will allow," "intendsto," "will likely result," "are expected to," "will continue," "is anticipated,""estimate," "project," or similar expressions, or the negative of such words orphrases, are intended to identify "forward-looking statements." We have basedthese forward-looking statements on our current expectations and projectionsabout future events. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on GLYCOMIMETICS : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) – marketscreener.com

Toward a Pharmacology of Resolution – Harvard Magazine

Posted: Published on May 1st, 2020

Of all the human immune systems extraordinary capabilities, its capacity to regenerate and restore normal physiological function after an injury or infection is probably the least well understood. The process thatresolvesinflammation is separate from the familiar immune responses characterized by fever, redness, and swelling.Resolution of inflammationis controlled by a group of molecules called specialized pro-resolving mediators, or SPMs. These are distinct from other immune-system signaling molecules not only in their compositionthey are lipids (fat-based) rather than proteinsbut in their action: familiar immune cells destroy or engulf invaders and damaged cells, but pro-resolving mediators speed the healing process and can even prevent inflammatory diseases from taking hold in the first place Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Toward a Pharmacology of Resolution – Harvard Magazine

What Happens When You Add Other Drugs To Your LSD Trip? – VICE

Posted: Published on May 1st, 2020

This article originally appeared on VICE US. Some drugs just pair well together: coffee and cigarettes, alcohol and cocaine, weed and pretty much anything Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on What Happens When You Add Other Drugs To Your LSD Trip? – VICE

COVID-19: What’s RNA research got to do with it? – University of Rochester

Posted: Published on May 1st, 2020

April 28, 2020 Rochester research into RNA structure and function provides key information for developing coronavirus treatments. Viruses like the coronavirus that causes COVID-19 are able to unleash their fury because of a devious weapon: ribonucleic acid, also known as RNA Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on COVID-19: What’s RNA research got to do with it? – University of Rochester

Fresh Produce In Short Supply? Prioritize This Veggie In Your Diet – mindbodygreen.com

Posted: Published on April 25th, 2020

"Sea vegetables are a great addition to a healthy diet right now, and always," registered dietitian Abby Cannon, J.D., R.D., CDN, says. The veggie variety, which includes kelp, nori, spirulina, chlorella, and kombuto name a fewis rich in vitamins and minerals like iron, copper, manganese, folate, zinc, sodium, calcium, and magnesium. What's more, sea vegetables provide antioxidants, like vitamins A, C, E and beta-carotene, according to doctor of pharmacology Lauren Tanabe, Ph.D. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Fresh Produce In Short Supply? Prioritize This Veggie In Your Diet – mindbodygreen.com

Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -…

Posted: Published on March 29th, 2020

Study missed primary endpoint of mean time to conversion of SVT to SR over a five-hour period following dosing (p=0.12) Etripamil showed rapid conversion of SVT to SR during the first 45 minutes (p=0.02), consistent with its known pharmacology Study demonstrated a positive safety profile showing etripamil was well tolerated in the at-home setting Small number of placebo patients and prolonged efficacy measurement period confounded results Company plans to discuss next steps with regulators and continue its full PSVT clinical program, including NODE-301B, NODE-302 and NODE-303 Company to host conference call today at 5:00 p.m. ET MONTREAL and CHARLOTTE, N.C Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -…

The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound…

Posted: Published on March 29th, 2020

March 25, 2020 18:35 ET | Source: ReportLinker New York, March 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cardiac Safety Services Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05872122/?utm_source=GNW The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Safety Services Market including are Banook Group, Bioclinica, BioTelemetry, Inc., ERT, Inc., Labcorp, Biotrial, Celerion, Inc., Certara, L.P., IQVIA, Medpace, Ncardia, PhysioStim, Richmond Pharmacology, and Shanghai Medicilon Inc.. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound…

Page 9«..891011..»